• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

联芳基和噻吩修饰的双芳基烷基羧酸衍生物的合成及抗血吸虫活性。

Synthesis and antischistosomal activity of linker- and thiophene-modified biaryl alkyl carboxylic acid derivatives.

机构信息

Institute of Pharmaceutical Chemistry, Philipps University Marburg, Marburg, Germany.

BFS, Institute of Parasitology, Justus Liebig University Giessen, Giessen, Germany.

出版信息

Arch Pharm (Weinheim). 2021 Dec;354(12):e2100259. doi: 10.1002/ardp.202100259. Epub 2021 Sep 15.

DOI:10.1002/ardp.202100259
PMID:34523746
Abstract

Schistosomiasis is a neglected tropical disease caused by blood flukes of the genus Schistosoma and causes severe morbidity in infected patients. In 2018, 290.8 million people required treatment, and 200,000 deaths are reported per year. Treatment of this disease depends on a single drug, praziquantel (PZQ). However, in the past few years, reduced sensitivity of the parasites toward PZQ has been reported. Therefore, there is an urgent need for new drugs against this disease. In the past few years, we have focused on a new substance class called biaryl alkyl carboxylic acid derivatives, which showed promising antischistosomal activity in vitro. Structure-activity relationship (SAR) studies of the carboxylic acid moiety led to three promising carboxylic amides (morpholine, thiomorpholine, and methyl sulfonyl piperazine) with an antischistosomal activity down to 10 µM (morpholine derivative) and no cytotoxicity up to 100 µM. Here, we show our continued work on this substance class. We investigated, in extended SAR studies, whether modification of the linker and the thiophene ring could improve the antischistosomal activity. We found that the exchange of the alkyl linker by a pentadienyl or benzyl linker was tolerated and led to similar antischistosomal effects, whereas the exchange of the thiophene ring was not tolerated. Our data suggest that the thiophene ring is important for the antischistosomal activity of this compound class.

摘要

血吸虫病是一种由血吸虫属的血吸病虫引起的被忽视的热带病,会给感染患者带来严重的发病。2018 年,有 2.908 亿人需要治疗,每年报告有 20 万人死亡。这种疾病的治疗取决于一种药物,即吡喹酮(PZQ)。然而,在过去几年中,已经报道了寄生虫对 PZQ 的敏感性降低。因此,迫切需要针对这种疾病的新药。在过去的几年中,我们专注于一种新的物质类别,称为联芳基烷基羧酸衍生物,它在体外表现出有希望的抗血吸虫活性。羧酸部分的构效关系(SAR)研究导致了三种有前途的羧酸酰胺(吗啡啉、硫吗啉和甲基磺酰基哌嗪),其抗血吸虫活性低至 10μM(吗啡啉衍生物),且在 100μM 时无细胞毒性。在这里,我们展示了我们在这个物质类别上的持续工作。我们在扩展的 SAR 研究中调查了是否可以通过修饰连接子和噻吩环来提高抗血吸虫活性。我们发现,用戊二烯基或苄基连接子取代烷基连接子是可以耐受的,并且导致类似的抗血吸虫作用,而噻吩环的替换则不能耐受。我们的数据表明,噻吩环对于该化合物类别的抗血吸虫活性很重要。

相似文献

1
Synthesis and antischistosomal activity of linker- and thiophene-modified biaryl alkyl carboxylic acid derivatives.联芳基和噻吩修饰的双芳基烷基羧酸衍生物的合成及抗血吸虫活性。
Arch Pharm (Weinheim). 2021 Dec;354(12):e2100259. doi: 10.1002/ardp.202100259. Epub 2021 Sep 15.
2
Biarylalkyl Carboxylic Acid Derivatives as Novel Antischistosomal Agents.联芳基烷基羧酸衍生物作为新型抗血吸虫药
ChemMedChem. 2016 Jul 5;11(13):1459-68. doi: 10.1002/cmdc.201600127. Epub 2016 May 9.
3
Recent Advances in the Synthesis of Antischistosomal Drugs and Agents.抗血吸虫病药物及制剂合成的最新进展
Mini Rev Med Chem. 2017;17(5):467-484. doi: 10.2174/1389557513666131119204558.
4
SAR of a new antischistosomal urea carboxylic acid.一种新型抗血吸虫尿素羧酸的比吸收率
Bioorg Med Chem Lett. 2018 Dec 15;28(23-24):3648-3651. doi: 10.1016/j.bmcl.2018.10.039. Epub 2018 Oct 25.
5
Disulfiram and dithiocarbamate analogues demonstrate promising antischistosomal effects.二硫化硒和二硫代氨基甲酸盐类似物表现出有前景的抗血吸虫效果。
Eur J Med Chem. 2022 Nov 15;242:114641. doi: 10.1016/j.ejmech.2022.114641. Epub 2022 Aug 18.
6
From dithiocarbamates to branched dithiocarbazates: Compounds with potent antischistosomal activity.从二硫代氨基甲酸盐到支链二硫代卡巴酸盐:具有强大抗血吸虫活性的化合物。
Arch Pharm (Weinheim). 2023 Mar;356(3):e2200491. doi: 10.1002/ardp.202200491. Epub 2022 Dec 8.
7
Chemotherapy for Fighting Schistosomiasis: Past, Present and Future.化疗治疗血吸虫病:过去、现在和未来。
ChemMedChem. 2018 Nov 20;13(22):2374-2389. doi: 10.1002/cmdc.201800572. Epub 2018 Nov 7.
8
Development of Biarylalkyl Carboxylic Acid Amides with Improved Anti-schistosomal Activity.具有增强抗血吸虫活性的联芳基烷基羧酸酰胺的研发
ChemMedChem. 2019 Nov 6;14(21):1856-1862. doi: 10.1002/cmdc.201900423. Epub 2019 Sep 18.
9
Could we expect new praziquantel derivatives? A meta pharmacometrics/pharmacoinformatics analysis of all antischistosomal praziquantel derivatives found in the literature.我们能否期待新的吡喹酮衍生物?对文献中所有抗血吸虫吡喹酮衍生物的荟萃药物代谢动力学/药物信息学分析。
SAR QSAR Environ Res. 2019 Jun;30(6):383-401. doi: 10.1080/1062936X.2019.1607898.
10
2-Aminothiophene-3-carboxylates and carboxamides as adenosine A1 receptor allosteric enhancers.2-氨基噻吩-3-羧酸盐和羧酰胺作为腺苷A1受体变构增强剂
Bioorg Med Chem. 2006 Apr 1;14(7):2358-65. doi: 10.1016/j.bmc.2005.11.018. Epub 2005 Nov 28.

引用本文的文献

1
Drug Repurposing and De Novo Drug Discovery of Protein Kinase Inhibitors as New Drugs against Schistosomiasis.蛋白激酶抑制剂的药物重定位和从头发现作为治疗血吸虫病新药。
Molecules. 2022 Feb 19;27(4):1414. doi: 10.3390/molecules27041414.